Kings Path Partners »

Iradimed shares owned by Kings Path Partners

Quarter-by-quarter ownership of Iradimed (IRMD) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Iradimed

Tip: Access up to 7 years of quarterly data

All positions including Iradimed held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iradimed by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 25k 50.29
2024-06-30 $1.1M 24k 43.94

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Tips Etf (SCHP)

View all positions for Kings Path Partners

Top funds holding Iradimed

BlackRock
Renaissance Technologies
Vanguard Group
Copeland Capital Management
Bares Capital Management
Ranger Investment Management
Dimensional Fund Advisors
Geode Capital Management
State Street Corporation
Russell Investments
Acadian Asset Management
HighTower Advisors
Soleus Capital Management
Morgan Stanley
Millennium Management

View all funds holding Iradimed